Published · unbundled · identical for every patient
What things cost, before you commit to anything
Cost shock mid-treatment is the largest single cause of abandoned cancer treatment in India. So the money conversation happens first, in writing.
Why nothing here costs ₹500
A ₹500 consultation buys a prescription. It cannot buy a proper history, an examination, a records review, a written plan and a next step, which is the only kind of appointment we run.
Everything performed elsewhere, assays, imaging, procedures, admission, medicines, is billed to you by whoever performs it, at its own rate. We show you that rate before you commit, and we negotiate it with the provider on your behalf.
Priced on their own · never inside a package
The two lines people ask about
Precision oncology session: Dr Bharat Kwatra
Complex cancer cases, molecular decision-making and multidisciplinary review. Head of Computational Precision Oncology and chair of the molecular tumour board.
₹15,000 – ₹25,000
Book this session
Navigator
OnKommon Navigator
A named person who books the tests, chases the reports, holds the dates, runs the recall and answers the phone, across every facility your care touches.
₹3,000 / month · ₹30,000 / year
What a navigator doesWhere an OnKommon Decipher interpretation already exists for your case, every written opinion below is charged at 50% of the published fee. The interpretation work is already done, so you should not pay for it twice. How Decipher works →
Consultation
Every consultation ends in a written plan you keep.
| Service | Fee | What it includes |
|---|---|---|
| Cancer risk assessment | No charge | Assessment and a written next step. No testing, no imaging, no obligation. |
| General & family medicine | ₹2,000 | Extended consultation, examination, records review and a written plan. |
| Specialty medicine OPD | ₹2,500 – ₹3,500 | Cardiology, gastroenterology, dermatology, endocrinology, pulmonology, nephrology. |
| Surgical opinion | ₹3,000 – ₹4,500 | Orthopaedics, robotic, bariatric, general, gynaecology, ENT, urology. Senior consultant, consult-only. |
| Psychotherapy & psycho-oncology | ₹2,500 – ₹3,500 | Per session. Course packages at 15–20% below single-session pricing. |
| Precision oncology, new patient | ₹5,000 – ₹7,500 | Extended consultation, option set, written summary, testing decision, board listing. |
| Precision oncology, follow-up | ₹2,500 – ₹3,500 | Interval history, toxicity and response review, revised written plan. |
| Site-specific cancer clinic | ₹4,000 – ₹6,000 | Breast, GI, thoracic, head & neck, gynae-oncology, haemato-oncology. |
| Supportive care clinics | ₹2,000 – ₹3,000 | Palliative, nutrition, rehabilitation, sexual health after cancer. |
| Precision oncology session: Dr Bharat Kwatra | ₹15,000 – ₹25,000 | Complex cases, molecular decision-making and multidisciplinary review. |
| Tele-consultation | Same fee | Priced identically to in person. The work is the same; only the room is missing. |
Indicative bands for our own professional services, effective 1 September 2026, exclusive of applicable taxes. The exact fee within a band depends on the consultant and case complexity, and is confirmed before the service is delivered.
Written opinions
Halved where an OnKommon Decipher interpretation already exists for your case.
| Format | Fee | With Decipher | Turnaround |
|---|---|---|---|
| Standard second opinion | ₹8,000 | ₹4,000 | 5–7 working days |
| Molecular second opinion | ₹18,000 | ₹9,000 | Faster where testing exists |
| Comprehensive board opinion | ₹30,000 | ₹15,000 | Next board + 72 hours |
| Pathology second opinion | ₹7,000 | ₹3,500 | 3–5 days from block receipt |
| Surgical second opinion | ₹5,000 | ₹2,500 | 3–5 working days |
| Radiation planning opinion | ₹8,000 | ₹4,000 | 3–5 working days |
| Treatment strategy review | ₹15,000 | ₹7,500 | 5–7 working days |
| Rare / complex case review | ₹30,000 | ₹15,000 | Next rare-case board |
| Rapid tier, any format | +60% | +60% | 48–72 hours, prioritised |
| NRI / international | USD 400 – 1,200 | Halved | Per tier chosen |
Assays, imaging, pathology processing and block retrieval are billed by the provider that performs them. The Decipher benefit applies to our opinion fee only.
Decision support, navigation and follow-up
| Service | Fee | Term |
|---|---|---|
| OnKommon Navigator | ₹3,000 / month ₹30,000 / year | Rolling monthly or annual. Separate invoice, never bundled. |
| Treatment-phase navigation | ₹30,000 | Six months, from the treatment decision. |
| Continued support after an opinion | ₹12,000 | Six months. Trial searches re-run, questions between appointments, and re-listing at the board when something material shifts. Quoted when your opinion is delivered, and only added if you ask for it. |
| Molecular advisory subscription | ₹48,000 / year | Your case re-reviewed as drugs, evidence and trials change. |
| Survivorship programme | ₹18,000 / year | Care plan, surveillance schedule, structured recall. |
| Board review for a referring physician | ₹25,000 | Next scheduled board + 72 hours. |
| Cost-aware therapy consultation | ₹4,000 | Costed course, biosimilar equivalence, scheme mapping. |
| Genetic counselling, pre + post package | ₹8,000 | Includes cascade plan and the written family letter. |
| Clinical trial eligibility consult | ₹5,000 | Waived where you enrol at a trial we are a site for. |
| Block & slide retrieval | ₹3,000 – ₹5,000 | Per retrieval, including transport and tracking. |
| Records vault | ₹2,000 setup · ₹1,500 / year | Digitisation, storage, retrieval, portable summary. |
Package prices are listed in full on the care packages page.
Four rules that do not bend
How we price
Nothing is bundled
Consultation, navigation, board review, assay and procedure are five services with five prices. You can buy one without the others.
Published means published
The same service costs the same to everyone. Hardship goes through a documented assistance policy with a named approver, never a discount at the desk.
We find you the rate
Two providers, two quotes, both named. A blended price hides a referral margin, and we will not quote one.
The recommendation is clinical
Where you are treated is decided clinically, and you see each provider’s own rate before you commit. Fee-splitting is prohibited for registered practitioners and we will not construct anything that behaves like it.
If the number is a problem
Say so early
It is a clinical conversation, not an embarrassing one, a patient who stops treatment for money has the same outcome as one whose treatment failed.
- Total course costing before treatment starts, not the price of cycle one.
- Clinically equivalent cheaper medicines, reviewed as a standing board item.
- Government schemes and assistance programmes, with the documentation done for you.
- Tiered testing. Not everyone needs comprehensive profiling.
Three annual tiers, Watch ₹78,000 (includes one ~₹20,000 screening panel per adult), Navigate ₹1,20,000 and Family Shield ₹90,000. A service subscription, not insurance: it never reimburses a treatment cost, and nothing is bundled that is not named. Line-by-line inclusions → · Employer cover →
POAS programme fees, spoke-board fees and partner terms are quoted per contract, they depend on bed count, case volume, spoke sites and modules taken. Ask for a proposal. The POAS programme →
For whoever maintains this site
What may and may not be published about fees in India
A working summary of the constraints this site respects, not legal advice. Have your adviser sign off the final wording.
Publish, and in some cases you must
- A rate list for services. Registered clinical establishments are expected to display rates at a conspicuous place, in English and the local language.
- Factual scope of services, what is covered, what is excluded, who provides it, where.
- Process and structure claims: panel composition, quorum rules, evidence tiering, turnaround, governance.
- Qualifications and council registration numbers of named practitioners, once verified.
- Taxes and third-party charges stated separately.
Never publish
- Any claim to cure, prevent, diagnose or treat cancer in an advertisement.
- Outcome figures, cure rates, survival percentages or success language.
- Superiority claims, or comparisons naming another institution.
- Patient testimonials, before-and-after imagery, or promotional case stories.
- Discounts, offers or limited-period pricing on a medical service.
- Any commercial term between KPCIRC and a provider. Those belong in the contract, never on a patient-facing page.
- Consultant remuneration, revenue-share terms or empanelment economics. Those belong in the contract, never on a patient-facing page.
- Prices for services not yet running.
